STAT3 and ovarian carcinoma: In this direction, numerous researchers have highlighted STAT3 as a potent therapeutic target for different phytocompounds such as polyphenols, organo-sulfur compounds, chalcones, etc. Previously, it has been envisaged that mTOR-STAT3 signaling was targeted by PEITC, which eventually led to cytotoxic effects on ovarian cancer cells [111].